During the next two decades, 78 million individuals are expected to turn 65 years of age in our country alone (the """"""""baby boomer"""""""" generation), and the number of individuals over the age of 85 will increase 5-fold. Therefore, the number of individuals with Alzheimer's disease will also increase exponentially. Individuals with Down's syndrome (PS) develop the neuropathological hallmarks of AD early in life, and most also experience dementia with age. In the previous grant period, we characterized a novel animal model for AD. mice with a segmental trisomy of chromosome 16 (Ts65Dn mice). The distal segment of mouse chromosome 16 is homologous to nearly the entire long arm of human chromosome 21, including the gene for amyloid precursor protein (APP), making this an interesting and useful model for AD. We found that these mice undergo a significant deterioration in working and reference memory as young adults (6 months of age), paralleled with an age-dependent elevation in APP and amyloid levels, reduction in growth factor levels and progressive loss of cholinergic neurons in the basal forebrain. There are still a number of key questions that need to be answered in terms of the degenerative process, both in this animal model and in the AD and DS brains: 1)What is the hierarchy of the degenerative process in the Ts65Dn (and the AD) brain?, 2) Is there a mobilization of defense mechanisms in the brain, and if so, when are they mobilized and when are they saturated?, and, finally, 3) Do the cholinergic cells actually die, or do they undergo """"""""phenotypic silencing""""""""? These are key questions that can be translated also to the AD and DS brain. The overall hypothesis of this proposal is:"""""""" Growth factor and amyloid systems interact in the AD brain, leading to deteriorating cholinergic function by means of oxidative stress and/or activation of inflammatory pathways"""""""". We propose to investigate this hypothesis by four different aims, which include investigations of the young and aged Ts65Dn mouse during normal conditions and when exposed to antioxidant and anti- inflammatory agents. The revised project contains a fourth aim, particularly targeting the mechanism of action for the minocycline treatment. The overall purpose of these studies is to investigate endogenous defense mechanisms as well as the degenerative process in itself, to explore if early intervention strategies can be employed. ? ? ?
| Buhusi, Mona; Etheredge, Chris; Granholm, Ann-Charlotte et al. (2017) Increased Hippocampal ProBDNF Contributes to Memory Impairments in Aged Mice. Front Aging Neurosci 9:284 |
| Hamlett, Eric D; Boger, Heather A; Ledreux, Aurélie et al. (2016) Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome. Curr Alzheimer Res 13:35-52 |
| Nie, Xingju; Hamlett, Eric D; Granholm, Ann-Charlotte et al. (2015) Evidence of altered age-related brain cytoarchitecture in mouse models of down syndrome: a diffusional kurtosis imaging study. Magn Reson Imaging 33:437-47 |
| Fortress, Ashley M; Hamlett, Eric D; Vazey, Elena M et al. (2015) Designer receptors enhance memory in a mouse model of Down syndrome. J Neurosci 35:1343-53 |
| Hartley, Dean; Blumenthal, Thomas; Carrillo, Maria et al. (2015) Down syndrome and Alzheimer's disease: Common pathways, common goals. Alzheimers Dement 11:700-9 |
| Iulita, M Florencia; Do Carmo, Sonia; Ower, Alison K et al. (2014) Nerve growth factor metabolic dysfunction in Down's syndrome brains. Brain 137:860-72 |
| Lockrow, Jason P; Fortress, Ashley M; Granholm, Ann-Charlotte E (2012) Age-related neurodegeneration and memory loss in down syndrome. Curr Gerontol Geriatr Res 2012:463909 |
| Fortress, Ashley M; Buhusi, Mona; Helke, Kris L et al. (2011) Cholinergic Degeneration and Alterations in the TrkA and p75NTR Balance as a Result of Pro-NGF Injection into Aged Rats. J Aging Res 2011:460543 |
| Lockrow, Jason; Boger, Heather; Gerhardt, Greg et al. (2011) A noradrenergic lesion exacerbates neurodegeneration in a Down syndrome mouse model. J Alzheimers Dis 23:471-89 |
| Lockrow, Jason; Boger, Heather; Bimonte-Nelson, Heather et al. (2011) Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome. Behav Brain Res 221:610-22 |
Showing the most recent 10 out of 55 publications
